Tuesday, April 16, 2019 3:29:12 PM
Falcon.
Thanks for feedback from DI conversation.
I personally find his remark about Sharpless, to be really very reassuring. I know too much can be read into these things, but I try to anyway!
I always had the impression that Gottleib was first and foremost 'a friend' to BP. And I expected that that would not do NWBO any favors. After all he had a list of paid links to BP, as long as two arms.
I don't suppose any incoming Commissioner will be entirely free of prior industry links, but Sharpless has less than most from what I have read.
As long as we get a level playing field that's all.
I suspect, regarding Gottleib's rather unexpected departure, there is much more than meets the eye.
But we will never know.
Unless perhaps he has come under some sort of particular scrutiny that called for a step down.
I wouldn't wish for any preferential treatment from a new Commissioner. So I'll take 'our friend' to mean 'not prejudiced against us'.
And that's all I would hope for.
If that is not too inaccurate a conclusion to draw, it makes a huge positive difference, at least the way I see it.
FWIW, I don't expect him to make anything more than a slight passing reference to DCVax, if that, at his upcoming UCLA appearance.
Thanks for feedback from DI conversation.
I personally find his remark about Sharpless, to be really very reassuring. I know too much can be read into these things, but I try to anyway!
I always had the impression that Gottleib was first and foremost 'a friend' to BP. And I expected that that would not do NWBO any favors. After all he had a list of paid links to BP, as long as two arms.
I don't suppose any incoming Commissioner will be entirely free of prior industry links, but Sharpless has less than most from what I have read.
As long as we get a level playing field that's all.
I suspect, regarding Gottleib's rather unexpected departure, there is much more than meets the eye.
But we will never know.
Unless perhaps he has come under some sort of particular scrutiny that called for a step down.
I wouldn't wish for any preferential treatment from a new Commissioner. So I'll take 'our friend' to mean 'not prejudiced against us'.
And that's all I would hope for.
If that is not too inaccurate a conclusion to draw, it makes a huge positive difference, at least the way I see it.
FWIW, I don't expect him to make anything more than a slight passing reference to DCVax, if that, at his upcoming UCLA appearance.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
